Optical Coherence Tomography, OCT, is being widely adopted for clinical, research and commercial skin-imaging applications
As the leading dermatological OCT system VivoSight Dx has completed over 200,000 patient scans and has been used in over 500 peer-reviewed publications worldwide.
During 2023 a total of 69 new peer-reviewed publications appeared featuring OCT imaging performed with VivoSight Dx. The Top-3 publication topics were:
- Microneedle Array Patch, MAP, studies
- Non-Melanoma Skin Cancer, NMSC, such as Basal Cell Carcinoma, BCC
- Inflammatory Skin Diseases, such as Atopic Dermatitis
The fastest growing publication topic in 2023 was Inflammatory Skin Disease, with a total of 10 peer-reviewed publications.
